Allergan Seeks To Pause Antitrust Suits Pending MDL Call
Allergan Inc. asked a Texas federal judge on Thursday to pause several suits alleging the company delayed the launch of generic versions of its dry-eye medication Restasis, in part by transferring...To view the full article, register now.
Already a subscriber? Click here to view full article